Viewing Study NCT06903312

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:44 PM
Ignite Modification Date: 2026-01-01 @ 11:31 AM
Study NCT ID: NCT06903312
Status: RECRUITING
Last Update Posted: 2025-07-03
First Post: 2025-03-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Cancer View
None Kidney Neoplasm View
None Immunotherapy View
None Kidney Cancer View
None Surgery Programmed View
None Radiotherapy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None renal cancer View
None primary tumor View
None cytoreductive nephrectomy View
None immunothreapy View
None radiotherapy View